Common Side Effects: How an Adult Swim Show Mirrors Real Mycological Economics

Common Side Effects is an Adult Swim animated series in which two friends discover the Blue Angel Mushroom — a fungus that cures all illnesses — while uncovering a pharmaceutical conspiracy to suppress it. The show's creators explicitly built it around their interest in why alternative medicine remains taboo despite real medicinal properties, and the series is inspired by real-life mycologist Paul Stamets. While the show uses conspiracy as drama, the economic logic it depicts is genuinely real. A mushroom that grows in someone's backyard is a fundamentally unmonetizable cure, which creates a genuinely strange problem for a healthcare system built around proprietary treatments. The pharmaceutical industry's incentive structure — where expensive Phase 3 clinical trials are only worthwhile if the resulting treatment can be patented and sold at premium prices — structurally disadvantages natural compounds that anyone could cultivate. This connects directly to the real state of medicinal mushroom research: 134 psilocybin clinical trials exist, with promising results for depression and anxiety, yet advancement toward mainstream therapeutic use is slow partly because the underlying compounds cannot be monopolized. The show dramatizes what researchers find genuinely frustrating — not a literal conspiracy, but an economic system that deprioritizes unpatentable cures. The fictional premise gains additional weight from the real biodiversity of undiscovered fungal chemistry — with an estimated 2–6 million fungal species and only ~150,000 formally described, the idea of a transformative compound hiding in an unstudied species is not science fiction but statistical probability.